Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The Chinese patients with chronic hepatitis C have a different genetic background, which had
been demonstrated to significantly influence their responses to pegylated interferon and
ribavirin. In this study, Chinese patients with Hepatitis C Virus genotype 1, 2/3, 6
infection were treated with pegylated interferon and ribavirin. Their response was compared
amongst different genotypes.